JP2005508382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508382A5 JP2005508382A5 JP2003542147A JP2003542147A JP2005508382A5 JP 2005508382 A5 JP2005508382 A5 JP 2005508382A5 JP 2003542147 A JP2003542147 A JP 2003542147A JP 2003542147 A JP2003542147 A JP 2003542147A JP 2005508382 A5 JP2005508382 A5 JP 2005508382A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- acid amide
- anthranilic acid
- tautomer
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0126901.8A GB0126901D0 (en) | 2001-11-08 | 2001-11-08 | Organic compounds |
| GBGB0212917.9A GB0212917D0 (en) | 2001-11-08 | 2002-06-05 | Organic compounds |
| PCT/EP2002/012445 WO2003040101A1 (en) | 2001-11-08 | 2002-11-07 | Anthranilic acid amides and pharmaceutical use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508382A JP2005508382A (ja) | 2005-03-31 |
| JP2005508382A5 true JP2005508382A5 (enExample) | 2005-11-17 |
| JP4179989B2 JP4179989B2 (ja) | 2008-11-12 |
Family
ID=26246753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542147A Expired - Fee Related JP4179989B2 (ja) | 2001-11-08 | 2002-11-07 | アントラニル酸アミド類およびその医薬的使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7067543B2 (enExample) |
| EP (2) | EP1446381B1 (enExample) |
| JP (1) | JP4179989B2 (enExample) |
| KR (1) | KR100633814B1 (enExample) |
| CN (1) | CN100467450C (enExample) |
| AR (1) | AR037261A1 (enExample) |
| AT (1) | ATE494278T1 (enExample) |
| AU (1) | AU2002342889B2 (enExample) |
| BR (1) | BR0213939A (enExample) |
| CA (1) | CA2462390C (enExample) |
| DE (1) | DE60238856D1 (enExample) |
| GB (2) | GB0126901D0 (enExample) |
| HR (1) | HRP20040412A2 (enExample) |
| IL (1) | IL161163A0 (enExample) |
| MX (1) | MXPA04004390A (enExample) |
| MY (1) | MY136322A (enExample) |
| NO (1) | NO326986B1 (enExample) |
| NZ (1) | NZ532587A (enExample) |
| PE (1) | PE20030540A1 (enExample) |
| PL (1) | PL368417A1 (enExample) |
| PT (1) | PT1446381E (enExample) |
| RS (1) | RS29404A (enExample) |
| RU (1) | RU2315756C2 (enExample) |
| TW (1) | TWI260985B (enExample) |
| WO (1) | WO2003040101A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7307088B2 (en) * | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
| GB0229022D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Ag | Organic Compounds |
| UA89035C2 (ru) | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Эфиры гидроксамовых кислот и их фармацевтическое применение |
| WO2005073165A1 (ja) | 2004-01-28 | 2005-08-11 | Mitsui Chemicals, Inc. | アミド誘導体及びその製造方法ならびにその殺虫剤としての使用方法 |
| DE102004009238A1 (de) * | 2004-02-26 | 2005-09-08 | Merck Patent Gmbh | Arylamid-Derivate |
| JPWO2006070878A1 (ja) * | 2004-12-28 | 2008-06-12 | アステラス製薬株式会社 | カルボン酸誘導体またはその塩 |
| EP2145873A1 (fr) * | 2008-06-17 | 2010-01-20 | Commissariat A L'energie Atomique | Nouveaux composés ayant une activité protectrice vis-à-vis de l'action de toxines et de virus au mode d'action intracellulaire |
| DK2346827T3 (da) | 2008-08-27 | 2014-02-03 | Leo Pharma As | Pyridinderivater som VEGFR-2 receptor og proteintyrosinkinasehæmmere |
| JP2011057661A (ja) * | 2009-08-14 | 2011-03-24 | Bayer Cropscience Ag | 殺虫性カルボキサミド類 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3226394A (en) * | 1964-06-16 | 1965-12-28 | Shulton Inc | Pyridylethylated anthranilamides and derivatives thereof |
| NZ277556A (en) * | 1993-12-27 | 1997-06-24 | Eisai Co Ltd | N-phenyl(alkyl)- and n-pyridyl(alkyl)anthranilic acid derivatives; intermediates |
| GB9511694D0 (en) * | 1995-06-09 | 1995-08-02 | Fujisawa Pharmaceutical Co | Benzamide derivatives |
| WO1998014449A1 (en) | 1996-10-02 | 1998-04-09 | Novartis Ag | Fused pyrazole derivatives and processes for their preparation |
| TW523506B (en) * | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
-
2001
- 2001-11-08 GB GBGB0126901.8A patent/GB0126901D0/en not_active Ceased
-
2002
- 2002-06-05 GB GBGB0212917.9A patent/GB0212917D0/en not_active Ceased
- 2002-11-06 TW TW091132668A patent/TWI260985B/zh active
- 2002-11-06 PE PE2002001081A patent/PE20030540A1/es not_active Application Discontinuation
- 2002-11-06 AR ARP020104236A patent/AR037261A1/es not_active Application Discontinuation
- 2002-11-07 AT AT02779536T patent/ATE494278T1/de active
- 2002-11-07 JP JP2003542147A patent/JP4179989B2/ja not_active Expired - Fee Related
- 2002-11-07 IL IL16116302A patent/IL161163A0/xx unknown
- 2002-11-07 CA CA2462390A patent/CA2462390C/en not_active Expired - Fee Related
- 2002-11-07 MY MYPI20024160A patent/MY136322A/en unknown
- 2002-11-07 US US10/494,222 patent/US7067543B2/en not_active Expired - Fee Related
- 2002-11-07 RS YUP-294/04A patent/RS29404A/sr unknown
- 2002-11-07 NZ NZ532587A patent/NZ532587A/en not_active IP Right Cessation
- 2002-11-07 KR KR1020047007000A patent/KR100633814B1/ko not_active Expired - Fee Related
- 2002-11-07 CN CNB028214307A patent/CN100467450C/zh not_active Expired - Fee Related
- 2002-11-07 PL PL02368417A patent/PL368417A1/xx not_active Application Discontinuation
- 2002-11-07 MX MXPA04004390A patent/MXPA04004390A/es active IP Right Grant
- 2002-11-07 WO PCT/EP2002/012445 patent/WO2003040101A1/en not_active Ceased
- 2002-11-07 EP EP02779536A patent/EP1446381B1/en not_active Expired - Lifetime
- 2002-11-07 EP EP10180423A patent/EP2269988B1/en not_active Expired - Lifetime
- 2002-11-07 HR HR20040412A patent/HRP20040412A2/hr not_active Application Discontinuation
- 2002-11-07 DE DE60238856T patent/DE60238856D1/de not_active Expired - Lifetime
- 2002-11-07 AU AU2002342889A patent/AU2002342889B2/en not_active Ceased
- 2002-11-07 BR BR0213939-1A patent/BR0213939A/pt not_active IP Right Cessation
- 2002-11-07 PT PT02779536T patent/PT1446381E/pt unknown
- 2002-11-07 RU RU2004117548/04A patent/RU2315756C2/ru not_active IP Right Cessation
-
2004
- 2004-05-25 NO NO20042137A patent/NO326986B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2215626T3 (es) | N-cianomethil amidas como inhibidores de proteasas. | |
| RU2214997C2 (ru) | Производные адамантана, способ их получения, фармацевтическая композиция и способ получения фармацевтической композиции | |
| JP2005511602A5 (enExample) | ||
| JP2005508293A5 (enExample) | ||
| JP2004532209A5 (enExample) | ||
| RU2005111969A (ru) | Производные пирролидона в качестве ингибиторов моноаминоксидазы в (мао-в) | |
| JP2006501295A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2001510154A5 (enExample) | ||
| JP2011504485A5 (enExample) | ||
| JP2006526630A5 (enExample) | ||
| JP2006503809A5 (enExample) | ||
| JP2009544620A (ja) | 自己免疫疾患及び炎症のためのプロリン尿素ｃｃｒ１アンタゴニスト | |
| JP2005513123A5 (enExample) | ||
| JP2010501587A5 (enExample) | ||
| JPH10279578A5 (enExample) | ||
| JP2004534096A5 (enExample) | ||
| WO2002002542A1 (fr) | Compose annulaire a cinq chainons | |
| JP2005508382A5 (enExample) | ||
| RU2008143232A (ru) | Новый класс ингибиторов гистондеацетилаз | |
| RU96121937A (ru) | Производные тропан-2-альдоксима в качестве ингибиторов обратного захвата нейротрансмиттеров | |
| JP2005510457A5 (enExample) | ||
| BE1009571A3 (fr) | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant. | |
| JP2004525183A5 (enExample) | ||
| CA2463968A1 (en) | Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |